Filter posts

Steps to Improve Competition in the Prescription Drug Marketplace

Recently on BIOtechNOW, we shared Three Encouraging Steps on Prescription Drug Costs which looked at recent …

FDA’s Historic Gene Therapy Approvals Could Be Beginning of the End of Blood Cancer

In his inaugural address this June as chairman of the world’s largest biotechnology industry group, …

Expanded Access – It Continues to Make Headlines

The recent Senate passage of S. 204, the Trickett Wendler, Frank Mongiello, and Jordan McLinn …

Agriculture 101: Asking Hard Questions And Digging For Answers

Headed back to school? So is this teacher, who shares how she encourages her students …

Three Encouraging Steps on Prescription Drug Costs

It’s a refrain you hear often in the news: Drug costs are soaring and nothing …

ICYMI: Reagan-Udall Foundation Launches Expanded Access Navigator for Patients and Physicians

The Reagan-Udall Foundation for the Food and Drug Administration (FDA) recently announced the release of …

The Dangers of Drug Importation

The United States is the leader in biopharmaceutical innovation and in guaranteeing that our prescription …

Patients Battle with Insurers for Prescription Drug Coverage

Patients with a difficult or rare disease are no strangers to adversity. There is the …

ICYMI: Op-Ed by Rep. Gus Bilirakis on Lowering Drug Costs

Yesterday, U.S. Representative Gus Bilirakis of Florida published an op-ed outlining how to “Lower Drug …

ICYMI: Jim Greenwood’s Letter in NYT on Drug Importation

Yesterday, the New York Times published a letter to the editor from BIO’s President and …